Please ensure Javascript is enabled for purposes of website accessibility

2017 J.P. Morgan Healthcare Conference Roundup

By Kristine Harjes – Updated Jan 17, 2017 at 9:52AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

All your Motley Fool coverage of the JP Morgan Healthcare Conference in one place.

Image source: Getty Images.

The annual J.P. Morgan Healthcare Conference, often called the Superbowl of biotech, kicked off on January 9, 2017.

The Motley Fool has you covered with reports on company presentations and themes from the conference. Check back daily for updates!

PS -- if you're interested in checking out how much things have changed since this time in 2016, here's last year's landing page.

The Motley Fool owns shares of and recommends Celgene, Gilead Sciences, Illumina, Ionis Pharmaceuticals, and Valeant Pharmaceuticals. The Motley Fool recommends Johnson and Johnson and Vertex Pharmaceuticals. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.